How did you find the quarterly results of Apollo Hospitals for Q3?

Apollo Hospitals reported one more quarter of solid quarterly results. With much of its capital expansion already done, the incremental revenues are directly contributing to the bottom line of the company. Dec-21 quarter was another quarter of solid growth across verticals for Apollo Hospitals, which include the hospitals, clinics and pharmacy segments of the company. Here is a gist of the Apollo story in numbers for Q3.

Apollo Hospitals reported 31.9% sales growth at Rs.3,639 crore. Revenues from the core healthcare services business saw 40.3% growth yoy at Rs.2,024 crore. Sequential revenues were marginally lower by -2.10% yoy. The pharmacy distribution vertical saw revenues higher by 16% yoy at Rs.1,307 crore. Even the clinics verticals grew revenues 59% yoy at Rs.313 crore. During Q3, Apollo Hospitals raised a sum of Rs.1,170 crore through a QIP placement of 46.6 lakh shares at a placement price of Rs.2,511 per share.

Operating profits increased 65.14% yoy to Rs.438.03 crore in the Dec-21 quarter. However, sequential profits were lower by -6.85%. Healthcare services vertical saw operating profits higher by a very robust 102% yoy at Rs.382 crore. The clinics vertical saw operating profits grow almost 4-fold at Rs.25 crore, on a small base. However, pharmacy distribution operating profits fell -55%. There was a 35% spike in materials cost, largely offset by inventory efficiency gains. OPM improved from 9.61% to 12.04% in the Dec-21 quarter.

Net Profits for Dec-21 quarter were up 75.1% at Rs.228.37 crore as the strong operating performance of Apollo Hospitals got transmitted effectively and seamlessly to the bottom line. PAT margins were up from 4.73% in the Dec-20 quarter to 6.28% in the Dec-21 quarter. However, it must be noted that the PAT margins were lower by 49 bps on sequential basis.